AA
AlphaCentric Advisors’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-110,000
| Closed | -$875K | – | 269 |
|
|
2021
Q3 | $875K | Buy |
110,000
+17,500
| +19% | +$139K | 0.22% | 39 |
|
|
2021
Q2 | $644K | Buy |
92,500
+71,500
| +340% | +$498K | 0.17% | 48 |
|
|
2021
Q1 | $166K | Buy |
21,000
+17,000
| +425% | +$134K | 0.06% | 108 |
|
|
2020
Q4 | $31K | Buy |
4,000
+1,000
| +33% | +$7.75K | 0.01% | 195 |
|
|
2020
Q3 | $21K | Buy |
+3,000
| New | +$21K | 0.01% | 146 |
|